当前位置:首页 - 行情中心 - 开立医疗(300633) - 财务分析

开立医疗

(300633)

  

流通市值:114.28亿  总市值:114.28亿
流通股本:4.33亿   总股本:4.33亿

开立医疗(300633)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.34亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益311914.85万元,未分配利润140345.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产411601.62万元,负债99686.77万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,459,311,230.15964,264,625430,012,001.932,013,856,558.55
营业总成本1,499,658,882.65955,582,429.16444,124,458.111,893,816,500.89
其他经营收益
营业利润9,591,435.5834,472,560.487,571,345.71121,555,950.82
利润总额8,957,251.4334,808,519.657,136,177.66120,189,228.74
净利润33,511,062.1147,030,261.688,074,620.52142,397,376.09
每股收益
其他综合收益9,759,243.34-3,848,775.414,674,919.5-7,777,830.84
综合收益总额43,270,305.4543,181,486.2712,749,540.02134,619,545.25
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,673,062,414.672,604,158,805.182,645,522,089.152,974,995,087.77
非流动资产:
非流动资产合计1,442,953,795.861,413,611,125.951,350,318,398.541,338,002,067.46
资产总计4,116,016,210.534,017,769,931.133,995,840,487.694,312,997,155.23
流动负债:
流动负债合计880,344,233.44788,048,411.4750,031,277.731,083,288,724.37
非流动负债:
非流动负债合计116,523,459.73114,207,812.55121,291,199.53121,485,951.45
负债合计996,867,693.17902,256,223.95871,322,477.261,204,774,675.82
所有者权益(或股东权益):
归属于母公司股东权益合计3,119,148,517.363,115,513,707.183,124,518,010.433,108,222,479.41
股东权益合计3,119,148,517.363,115,513,707.183,124,518,010.433,108,222,479.41
负债和股东权益合计4,116,016,210.534,017,769,931.133,995,840,487.694,312,997,155.23
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,620,769,293.861,085,584,203.39442,619,029.862,546,012,605.75
经营活动现金流出小计2,001,741,353.861,335,883,536.41727,483,571.772,239,354,350.37
经营活动产生的现金流量净额-380,972,060-250,299,333.02-284,864,541.91306,658,255.38
投资活动产生的现金流量:
投资活动现金流入小计685,529,722.35655,974,893.76499,535,533.271,015,994,445.02
投资活动现金流出小计359,981,279.26286,844,363.48179,389,108.541,607,132,005.73
投资活动产生的现金流量净额325,548,443.09369,130,530.28320,146,424.73-591,137,560.71
筹资活动产生的现金流量:
筹资活动现金流入小计245,292,590.89142,916,002.4221,167,720.37443,470,753.5
筹资活动现金流出小计344,117,242.47318,536,693.98175,584,712.35361,233,644.87
筹资活动产生的现金流量净额-98,824,651.58-175,620,691.56-154,416,991.9882,237,108.63
汇率变动对现金及现金等价物的影响378,972.51727,637.481,084,263.85-426,060.23
现金及现金等价物净增加额-153,869,295.98-56,061,856.82-118,050,845.31-202,668,256.93
期末现金及现金等价物余额1,368,692,476.791,466,499,915.951,404,510,927.461,522,561,772.77
补充资料:
现金及现金等价物的净增加额--56,061,856.82--202,668,256.93
最新报告期:2025-11-13
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投王在存,贺菊颖0.330.781.022025-11-13
兴业证券孙媛媛,黄翰漾0.390.771.062025-11-08
东海证券杜永宏0.781.051.362025-11-03
中金公司俞波,张琎,冯喜鹏0.360.83--2025-10-29
华泰证券代雯,高鹏,杨昌源0.410.861.042025-10-28
TOP↑